About this document
Intranasal Midazolam for Dyspnoea Relief by Fernanda Campos is a document available to read on EtoBox.
This study evaluated the efficacy of intranasal midazolam for alleviating dyspnoea in patients with life-limiting diseases through a randomized, double-blind controlled trial. Results indicated no significant difference in dyspnoea scores between the midazolam and placebo groups, with both showing a similar positive response rate. The findings emphasize the necessity of placebo-controlled trials in determining effective clinical practices for managing breathlessness.
- Author
- Fernanda Campos
- Language
- EN